Enlivex Therapeutics Ltd. (Formerly Tolarex)
Sector: Biotechnology - Therapeutics
Medical Field: Immune Disorders
Technological Field: Immune Modulation
Year Established: 2005
Enlivex is a biotechnology company focused on the development of cell therapies for the induction of immune tolerance in autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, and Crohn’s disease.